Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer
Laboratory Medicine · 2025
DOI: 10.1093/labmed/lmae097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Tuba Taşkan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Afyonkarahisar Health Sciences University, Faculty of Pharmacy, Department of Biochemistry, Afyonkarahisar, Türkiye. Hauptthemen laut MEDLINE: Breast Neoplasms, Proto-Oncogene Proteins c-ret, Genetic Predisposition to Disease, Neurturin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gazi University Scientific Research Projects.
Abstract (Originalsprache)
Background
Gene polymorphisms of rearranged during transfection (RET) and its ligand neurturin (NRTN) are one of the focus of studies in the investigation of cancer pathogenesis, invasion, and metastasis. In this study, we aimed to examine the possible risk of breast cancer between RET G691S, L769L, S904S, and NRTN IVSI-663 polymorphisms and to evaluate serum NRTN, brain-derived neurotrophic factor (BDNF), matrix metalloproteinase (MMP)-2, MMP-9, and focal adhesion kinase (FAK) levels.
Methods
The study consists of 110 breast cancer patients and 110 controls. Polymorphisms were detected by the polymerase chain reaction method from study groups whole blood.
Results
The NRTN IVSI-663 polymorphism in G allele has been found to be 1.54 fold increased the risk of breast cancer, however AA genotype has been found 0.43 fold decreased the risk of breast cancer (P < .05, P < .05, respectively). Study groups showed a similar profile for RET G691S, L769L, S904S allele frequencies and genotype distributions (P > .05). In the patient group, significant increase in serum NRTN and FAK levels and decrease in MMP-2 and MMP-9 levels were found (P < .05, P < .05, P < .05, P < .05, respectively).
Discussion
In summary that increased breast cancer risk with the G allele in NRTN gene IVSI-663 polymorphism, as well as the increased serum NRTN and FAK levels, will contribute to the diagnosis, prognosis and determination of new treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Afyonkarahisar Health Sciences University, Faculty of Pharmacy, Department of Biochemistry, Afyonkarahisar, Türkiye.
- Chris O'brien Lifehouse Hospital, General Surgery Outpatient Clinic, Sydney, Australia.
- Gazi University, Faculty of Medicine, Department of General Surgery, Ankara, Türkiye.
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital General Surgery Outpatient Clinic, Ankara, Türkiye.
- Gazi University, Faculty of Pharmacy, Department of Biochemistry, Ankara, Türkiye.
ORCID-Profile: Tuba Taşkan, Farshad Noori, Osman Kurukahvecioğlu, Niyazi Karaman, Aymelek Gönenç
Förderung
- Gazi University Scientific Research Projects
Zitieren
APA
Taşkan, T., Noori, F., Kurukahvecioğlu, O., Karaman, N., & Gönenç, A. (2025). Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer. Laboratory Medicine. https://doi.org/10.1093/labmed/lmae097
Vancouver
Taşkan T, Noori F, Kurukahvecioğlu O, Karaman N, Gönenç A. Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer. Laboratory Medicine. 2025. doi:10.1093/labmed/lmae097
BibTeX
@article{Takan2025,
author = {Taşkan, Tuba and Noori, Farshad and Kurukahvecioğlu, Osman and Karaman, Niyazi and Gönenç, Aymelek},
title = {Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer},
journal = {Laboratory Medicine},
year = {2025},
doi = {10.1093/labmed/lmae097}
}
EUVIMED